Myelodysplastic syndromes (MDS) are a group of cancers sometimes associated with high MCV. The American Cancer Society estimates that about 10,000 people in the United States receive a diagnosis ...

Myelodysplastic syndrome (MDS) can be difficult to diagnose. Many people who are diagnosed with MDS go to their doctor with some or all of the symptoms typical of MDS. Other people are diagnosed with ...

The European Commission has approved Rytelo treatment in transfusion-dependent anemia due to very low–, low– or ...

Lower-risk MDS is a progressive blood cancer with high unmet need, where many patients with anemia become dependent on red blood cell transfusions, which can be associated with clinical ...